Fig. 1From: Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative studyStudy design showing the precision cohort as the group of patients who received treatment for metastatic colorectal cancer based on successful biopsy and drug screening performed in patient-derived tumor organoidsBack to article page